Group A (PSA/biopsy) consists of ERSPC [3], PLCO Cancer Screening Trial [4,17], Cluster randomised trial of PSA testing for Prostate cancer (CAP) [18], and Early Prostate Cancer Detection Programme (EPCDP) [19]. The gene discussed is KLK3; the disease is prostate cancer.